The long-term impact of antidepressant pharmacotherapy in India

Depression is a leading cause of disability and especially prevalent among low-income populations, where it may also perpetuate poverty.

From:
Foreign, Commonwealth & Development Office
Published
23 October 2025
Country:
India
Document Type:
Briefing
Theme:
Health
First published:
1 August 2025
Authors:
Bennett, D. and Angelucci, M.

Abstract

Despite the availability of effective treatments like anti-depressants, most people in low- and middle-income countries (LMICs) do not receive care, due to provider scarcity, stigma, and low awareness. Antidepressants are potentially scalable in LMICs, but little is known about their long-term effects.

This research is part of the G2LM Gender, Growth and Labour Markets in Low-Income Countries programme.

Citation

Bennett D and Angelucci M. ‘The long-term impact of antidepressant pharmacotherapy in India’ G2LM LIC Policy Brief No. 76, 2025

The long-term impact of antidepressant pharmacotherapy in India

Updates to this page

Published 23 October 2025
Contents